
Wednesday, February 19, 2025 11:52:58 AM
18 February 2025
Abstract
Cannabidiol (CBD), a nonpsychoactive compound from Cannabis, has various bioactive functions in humans and animals. Evidence suggests that CBD promotes muscle injury recovery in athletes, but whether and how CBD improves endurance performance remains unclear. Here we investigated the effects of CBD treatment on exercise performance in mice and assessed whether this effect involves the gut microbiome. CBD administration significantly increased treadmill running performance in mice, accompanied by an increase in oxidative myofiber composition. CBD also increased mitochondrial biogenesis and the expression of associated genes such as PGC-1a, phosphorylated CREB and AMPK in muscle tissue. Interestingly, CBD altered the composition of the gut microbiome, and antibiotic treatment reduced the muscle endurance-enhancing effects of CBD and mitochondrial biogenesis. We isolated Bifidobacterium animalis, a microbe increased by CBD administration, and named it KBP-1. Treatment with B. animalis KBP-1 in mice resulted in improved running performance. Whole-genome analysis revealed that B. animalis KBP-1 presented high expression of genes involved in branched-chain amino acid biosynthesis, expression of branched-chain amino acid release pumps and metabolism of lactic acid. In summary, our study identified CBD and B. animalis KBP-1 as potential endurance exercise-promoting agents.
https://www.nature.com/articles/s12276-025-01404-5
Recent CWBHF News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2025 11:08:39 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2025 11:08:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2025 01:31:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2025 09:23:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 08:46:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2024 12:14:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 12:08:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 01:35:51 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 08:55:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 07:46:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 05:17:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:11:15 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:08:40 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2024 10:04:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 11:00:55 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:13:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 11:09:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:08:30 AM
NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market • ELAB • Mar 27, 2025 11:20 AM
LaFleur Minerals Announces Memorandum of Understanding with Granada Gold on Milling Assessment for the Granada Gold Project Using the Beacon Gold Mill • LFLRF • Mar 27, 2025 8:40 AM
Nightfood Holdings (NGTF) Issues Shareholder Update on Imminent Strategic Acquisitions and Rapid Expansion in AI-Powered Hospitality Automation • NGTF • Mar 27, 2025 8:30 AM
ConnectM Secures Landmark Home and Building Electrification Project in India, Marking Strategic International Expansion • CNTM • Mar 27, 2025 7:05 AM
$SYNX - Could Silynxcom Be the Next 1000% Israeli Defense Tech Rocketship? (NYSE: SYNX) • SYNX • Mar 26, 2025 12:15 PM
ConnectM Issues Stockholder Letter from CEO & Chairman • CNTM • Mar 26, 2025 12:14 PM